Antibiotic nanoparticles boost antitumor immunity

Liposomes loaded with antibiotics eliminate intracellular bacteria in a colorectal cancer model, unleashing antitumor T cell immunity.

In cancer immunotherapy, stimulation of antitumor T cell responses requires recognition between T cell receptors and tumor-derived epitopes presented by the major histocompatibility complex class I (MHC-I)2. However, tumors with a low mutational burden have few neoantigens, which limits the repertoire of antitumor T cells3. Bacteria may enter both tumor cells and antigen-presenting cells in tumor tissues4, suggesting that microbial neoepitopes might engage antitumor T cell immunity, and several studies have reported that microbial peptide antigens can be presented by human tumor cells and can activate T cells ex vivo5,6. However, it has been difficult to exploit this phenomenon for cancer therapy.

This is a preview of subscription content, access via your institution

Access options

Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription

24,99 € / 30 days

cancel any time

Subscribe to this journal

Receive 12 print issues and online access

209,00 € per year

only 17,42 € per issue

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Log in

Learn about institutional subscriptions

Read our FAQs

Contact customer support

Fig. 1: Antibiotics-loaded liposomes kill intratumoral bacteria and elicit antitumor T cell immunity.

References

Wang, M. L. et al. Nat. Biotechnol. https://doi.org/10.1038/s41587-023-01957-8 (2023).

Article 
PubMed 
PubMed Central 

Google Scholar 

Kuai, R., Ochyl, L. J., Bahjat, K. S., Schwendeman, A. & Moon, J. J. Nat. Mater. 16, 489–496 (2017).

Article 
CAS 

Google Scholar 

Zamora, A. E., Crawford, J. C. & Thomas, P. G. J. Immunol. 200, 392–399 (2018).

Article 
CAS 
PubMed 

Google Scholar 

Galeano Niño, J. L. et al. Nature 611, 810–817 (2022).

Article 
PubMed 
PubMed Central 

Google Scholar 

Kalaora, S. et al. Nature 592, 138–143 (2021).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Naghavian, R. et al. Nature 617, 807–817 (2023).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Nejman, D. et al. Science 368, 973–980 (2020).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Seynhaeve, A. L. B., Amin, M., Haemmerich, D., van Rhoon, G. C. & Ten Hagen, T. L. M. Adv. Drug Deliv. Rev. 163-164, 125–144 (2020).

Article 
CAS 
PubMed 

Google Scholar 

Riquelme, E. et al. Cell 178, 795–806.e12 (2019).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Download references

Author information

Author notes

These authors contributed equally: Kai Han, Young Seok Cho.

Authors and Affiliations

Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, USA

Kai Han, Young Seok Cho & James J. Moon

State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing, China

Kai Han

Biointerfaces Institute, University of Michigan, Ann Arbor, MI, USA

Kai Han, Young Seok Cho & James J. Moon

Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA

James J. Moon

Corresponding author

Correspondence to
James J. Moon.

Ethics declarations

Competing interests

J.J.M. declares financial interests for board membership, as a paid consultant, for research funding, and/or as an equity holder in EVOQ Therapeutics and Saros Therapeutics.

About this article

Cite this article

Han, K., Cho, Y.S. & Moon, J.J. Antibiotic nanoparticles boost antitumor immunity.
Nat Biotechnol (2023). https://doi.org/10.1038/s41587-023-02046-6

Download citation

Published: 16 November 2023

DOI: https://doi.org/10.1038/s41587-023-02046-6

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : Nature.com – https://www.nature.com/articles/s41587-023-02046-6